|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Clinical significance of IgG Fc receptors and FcγR-directed immunotherapies 显示文摘 | Deo YM Graziano RF Repp R | 1997 | Immunol Today1997，18，3： | 1 |
| 2 | Enhanced killing of B lymphoma cells by granulocyte colony - stimulating factor - primed effector cells and Hu1D10-a humanized human 1eucocyte antigen DR antibody显示文摘 | Stockmeyer B Schiller M Repp R | 2002 | Br J Haematol2002，8，4： | 1 |
| 3 | Pretherapeutic identification of high risk acute myeloid leukemia (AML) patients from immunophenotypic,cytogenetic,and clinical parameters显示文摘 | VALET G REPP R LINK H et a1 | 2003 | Cytometry2003，53，1： | 1 |
| 4 | Phase 2 study of alemtuzumab (anti-CD52 monoclonal antibody) in patients with advanced mycosis fungoides/Sezary syndrome显示文摘 | Lundin J Hagberg H Repp R | 2003 | Blood2003，101，11： | 1 |
| 5 | Neutrophils express the high affinity receptor for IgG (Fc gamma RI, CI)64 ) after in vivo application of recombinant human granulocyte colony-stimulating factor 显示文摘 | Repp R Valerius T Sendler A | 1991 | Blood1991，78，4： | 1 |
| 6 | The addition of rituximab to a combination of fludarabine,cyclophosphamide,mitoxantrone (FCM) significantly increases the response rate and prolongs survival as compared with FCM alone in patients with relapsed and refractory follicular and mantle cell lymphomas:results of a prospective randomized study of the german low-grade lymphoma study group显示文摘 | Forstpointner R Dreyling M Repp R | 2004 | Blood2004，104，10： | 1 |
| 7 | The addition of rituximab to a combination of fludarabine,cyclophosphamide,mitoxantrone (FCM) significantly increases the response rate and prolongs survival as compared with FCM alone in patients with relapsed and refractory follicular and mantle cell lymphomas显示文摘 | Forstpointner R Drevling M Repp R | 2004 | Blood2004，104，10： | 1 |
| 8 | Immuno- phenotyping is an independent factor for risk stratification in AML 显示文摘 | Repp R Schaekel U Helm G Thiede C Soucek S Pascheberg U Wandt H Aulitzky W Bodenstein H Sonnen R Link H Ehninger G Gramatzki M AML- SHG Study Group | 2003 | Cytometry B Clin Cytom2003，53，1： | 1 |
| 9 | Definition of risk factors for death,end stage renal disease,and thromboembolic events in a monocontric cohort of 338 patients with systemic lupus erythematosus显示文摘 | Manger K Manger B Repp R | 2002 | Ann Rheum Dis2002，61，12： | 1 |
| 10 | Clinical relevance of Fcgammareceptor polymorphisms显示文摘 | Rascu A Repp R Westerdaal NA | 1997 | Ann NY Acad Sci1997，815，： | 1 |
| 11 | Phase 2 study of alemtuzumab (anti-CD52 monoclonal antibody) in patients with advanced mycosis fungoides/Sezary syndrome显示文摘 | Lundin J Hagberg H Repp R | 2003 | Blood2003，101，11： | 1 |
| 12 | The addition of rituximab to a combination of fludarabine, cyclophos- phamide, mitoxantrone (FCM) significantly increases the response rate and prolongs survival as compared with FCM alone in patients with relapsed and refractory follicular and mantle cell lymphomas: results of a prospective randomized study of the German Low-Grade Lymphoma Study Group显示文摘 | Forstpointner R Dreyling M Repp R | 2004 | Blood2004，104，10： | 1 |
| 13 | The addition of rituximab to a combination of fludarabine,cyclophosphamide,mitoxantrone (FCM) significantly increases the response rate and prolongs survival as compared with FCM alone in patients with relapsed and refractory follicular and mantle cell lymphomas:results of a prospective randomized study of the German Low-Grade Lymphoma Study Group显示文摘 | Forstpointner R Hanel A Repp R | 2004 | Blood2004，104，10： | 1 |
| 14 | Treatment of follicular and mantle cell lymphoma with rituximab after high-dose chemotherapy and autologous blood stem cell transplantation:a multicenter phase Ⅱ study显示文摘 | BRUGGER W HIRSCH J REPP R | 2002 | Blood2002，100，： | 1 |
| 15 | Phase I clinical trial of the bispecific antibody MDX-H210(anti-Fcgan mmRI× anti-HER-2/neu) in combination with Filgrastim (G-CSF)for treatment of advanced breaset cancer显示文摘 | Repp R van Ojik HH Valefius T | 2003 | Br J Cancer2003，89，12： | 1 |
| 16 | Sox-4 messenger RNA is expressed in the embryonic growth plate and regulated via the parathyroid hormone/parathyroid hormone-related protein receptor in osteoblast-like ceils 显示文摘 | Reppe S Rian E Jemtland R | 2000 | J Bone Miner Res2000，15，12： | 1 |
| 17 | Early Prediction of out come in head injuredpatieuts 显示文摘 | Young B Repp R P Morton J A | 2006 | J Neurvsurg2006，54，： | 1 |
| 18 | , Transcription of hepatitis B virus in peripheral blood mononuclear cells from persistently infected patients显示文摘 | Stoll-Becker S Repp R Glebe D | 1997 | J Virol1997，71，： | 1 |
| 19 | Immuno- phenotyping is an independent factor for risk stratifi cation in AML显示文摘 | REPP R SCHAEKEL U HELM G | 2003 | Cytometry B Clin Cytom2003，53，： | 1 |
| 20 | Cloning and characterization of AFX, the gene that fuses to MLL in acute leukemias with a t(X;ll)(q13;q23)显示文摘 | Borkhardt A Repp R Haas OA | 1997 | Oncogene1997，14，2： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员